How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

被引：0
|
作者：
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构：
[1] Univ Toyama, Dept Internal Med 2, Toyama, Japan
来源：
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2025年
关键词：
D O I：
10.1111/jce.16591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reply: How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
    Kino, Tabito
    Nogami, Akihiko
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025,
  • [2] OFF-LABEL USE OF NEW ORAL ANTICOAGULANTS IN ABLATION FOR ATRIAL FIBRILLATION
    Rodriguez, A. V.
    Andres, A. L.
    Villuendas, R.
    Montane, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 34 - 34
  • [3] Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation
    Sandhu, Amneet
    Kaltenbach, Lisa
    Chiswell, Karen
    Shimoga, Vijay
    Ashur, Carmel
    Pribish, Abby
    Fonarow, Gregg C.
    Piccini, Jonathan P.
    Ho, Michael
    Varosy, Paul D.
    Hess, Paul
    CIRCULATION, 2023, 148
  • [4] Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
    Alexandros Briasoulis
    Yubo Gao
    Chakradhari Inampudi
    Paulino Alvarez
    Rabea Asleh
    Elizabeth Chrischilles
    Enrique C. Leira
    Mary Vaughan-Sarrazin
    BMC Cardiovascular Disorders, 20
  • [5] Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
    Briasoulis, Alexandros
    Gao, Yubo
    Inampudi, Chakradhari
    Alvarez, Paulino
    Asleh, Rabea
    Chrischilles, Elizabeth
    Leira, Enrique C.
    Vaughan-Sarrazin, Mary
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [6] OUTCOMES OF OFF-LABEL DOSING OF DIRECT ORAL ANTICOAGULANTS IN MEDICARE BENEFICIARIES WITH ATRIAL FIBRILLATION
    Briasoulis, Alexandros
    Gao, Yubo
    Vaughan-Sarrazin, Mary
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 367 - 367
  • [7] Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?
    Poli, Daniela
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (03) : 286 - 289
  • [8] Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: A systematic review
    Santos, Joana
    Antonio, Natalia
    Rocha, Marilia
    Fortuna, Ana
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (03) : 533 - 547
  • [9] Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose
    Xu, Wenlin
    Lv, Meina
    Wu, Tingting
    Huang, Nianxu
    Zhang, Wang
    Su, Jun
    Dai, Hengfen
    Gu, Ping
    Huang, Xiaohong
    Du, Xiaoming
    Li, Ruijuan
    Zheng, Qiaowei
    Lin, Xiangsheng
    Liu, Yuxin
    Zhang, Min
    Liu, Xiumei
    Zhu, Zhu
    Zhang, Jinhua
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 184 - 190
  • [10] Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States
    Sandhu, Amneet
    Kaltenbach, Lisa A.
    Chiswell, Karen
    Shimoga, Vijay
    Ashur, Carmel
    Pribish, Abby
    Fonarow, Gregg C.
    Piccini, Jonathan P.
    Ho, P. Michael
    Varosy, Paul D.
    Hess, Paul L.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (12): : E010062
12345